LERNER LORENA RAQUEL (Chief Scientific Officer) sold 11.1% of their position (3.87K shares) of KEROS THERAPEUTICS, INC. on the open market
Open‑market sale worth $63.3K — a moderate reduction. Review remaining holdings and any 10b5‑1 plan disclosures.
S · 1 sale
Filed: 2/20/2026ACC: 0002081359-26-000002
Officer· Chief Scientific Officer
Since Feb 2026
-3.87K
Net shares
Net seller
$63.3K
Total sold
1
Open market trades
0B · 1S
1
Total transactions
3.87K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.87K
Price / share
$16.35
Trade value
$63.32K
% of position
11.1%
2/18/2026
35K→31.13K
Total
Net shares
−3.87K
Net value
-$63.32K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 2/18/2026 | S · Sale | −3.87K | $16.35 | $63.32K | 11.1% | 35K | 31.13K |
| Total | −3.87K | -$63.32K | ||||||
Derivative Transactions0
No derivative transactions reported